Previous laboratory research has shown that ivermectin could have anticancer effects because it promotes cell death and inhibits the growth of tumor cells. "It actually has been studied both with NIH funds and outside of NIH funds," Letai said.

A pulmonary embolism tied to colorectal cancer killed Catherine O’Hara. Here’s how common the event is among cancer patients - Nearly a dozen types of cancer are more likely to cause the venous clots

A new Stanford Medicine study reveals that colorblind men face 52% higher bladder cancer death risk because they can't see warning signs early enough.

The first study on deuterium-depleted water (DDW) concluded that a higher D/H ratio inside cells can trigger cell division. This was supported by lab experiments showing that lowering deuterium levels slowed cell growth, while increasing it accelerated it.

FDA approves pembrolizumab with chemotherapy for platinum-resistant ovarian cancer, showing significant survival benefits in clinical trials. The FDA has approved pembrolizumab (Keytruda) plus paclitaxel, with or without bevacizumab (Avastin) for the treatment of patients with platinum-resistant recurrent ovarian cancer. 1

Researchers recently tried an experiment: Gather people who had the same kind of lung cancer and put them on the same type of treatments to fire up their immune systems. The only difference was that half the group got their medications earlier in the day,

During a January 30 event, Anthony Letai, a cancer researcher the Trump administration installed as the director of the NCI in September, said the NCI was pursuing ivermectin.

Colorectal cancer is often spoken of as a single disease, but it actually refers to two related cancers: colon cancer and rectal cancer. The latter was recently revealed as the reason we lost the wonderful Catherine O'Hara earlier this year.

Dave Coulier entered complete remission after battling two cancers in 18 months. The "Full House" star credits early detection with saving his life.

Gov. Wes Moore (D), who calls quantum computing a “lighthouse industry” for Maryland, has secured more than $1 billion in funding to help create a local industry hub.

Roughly 37–40% of all new cancer cases in 2022—about 7.1 million—were linked to preventable causes, suggesting major opportunities for prevention.